Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Araújo Oliveira (Vila Nova de Famalicão, Portugal). Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD. 4705

Member's Comments

No comment yet.

Related content which might interest you: Minimal clinically important difference of the Brief-BESTest in COPD Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1 Year: 2020 Additive information from mMRC and CCQ in relation to COPD exacerbations Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Assessment of predictive factors for asthma exacerbations severity Source: Eur Respir J 2006; 28: Suppl. 50, 503s Year: 2006 Minimal clinically important difference of the clinical COPD questionnaire Source: Eur Respir J 2004; 24: Suppl. 48, 689s Year: 2004 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 Predictive validity of BODE index for anxious and depressive symptoms in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease Year: 2010 Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Fatigue in COPD: association with functional status and hospitalisations Source: Eur Respir J 2013; 41: 565-570 Year: 2013 Reliability and validity of the COPD and asthma fatigue scale Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 Correlation between COPD assessment test (CAT) and mMRC dyspnea scale in evaluationg COPD symptoms Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 The EQ-5D is responsive to recovery from a moderate COPD exacerbation Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Evaluating symptom outcomes in patients with COPD: reliability and validity of the breathlessness, cough and sputum scale Source: Eur Respir J 2001; 18: Suppl. 33, 461s Year: 2001 Karnofsky index as predictor of exacerbations in moderate and severe COPD patients Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016 Scales of assesment in COPD. Correlation with clinical and functional parameters Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Mortality predictive variables in the short-term before a COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006